Scholars Central

Research articlePublished 28 Jan 2016

A COMPARATIVE STUDY OF LABETALOL VERSUS METHYLDOPA IN THE TREATMENT OF PREECLAMPSIA

Authors: Jayanthy T, Kirana T, Nirmala S

Journal of Evidence-Based Medicine and Healthcare

Volume 3 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND To compare the efficacy and safety of labetalol versus Methyldopa in the management of preeclampsia. METHODOLOGY 100 pregnant women with preeclampsia were randomly assigned, 50 were treated with labetalol (Group A) and 50 with methyl dopa (Group B) alternatively with matching distribution. RESULTS Labetalol is effective & early onset of action with less side effects. The chances of spontaneous onset of labor was greater, those who were induced had better Bishops score. CONCLUSION Labetalol is safe, quicker control of blood pressure and lesser side effects and thus advantageous over methyldopa.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Evidence-Based Medicine and Healthcare.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Evidence-Based Medicine and Healthcare
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Jayanthy T”
  • BylineArticles whose byline prints “Kirana T”
  • BylineArticles whose byline prints “Nirmala S”